INDUCTION OF APOPTOSIS IN S-180 AND S-180R TUMOR CELLS BY ADRIAMYCIN IN VIVO

Apoptosis of tumor cells have become a newstandard for chemotherapy. It is useful to demonstrateinduction of apoptosis in tumor cells by anti-cancer drugsin vivo. We reported the results of apoptosis induction inmurine tumor cell line S-180 and it’s resistant cell linc S-180R by adriamycin in different dose and different time.We found that apoptosis in S-180 cells could be inducedby low dose of adriamycin, the apoptosis was started at 24h. after the administration, and reached to 62.5% of thecells to apptosis until 72 h. Comparison with theparental cell line, only 13% of S-180R cells wereapoptosed. At high dose, 20% of S-180R cells wereapoptosed, whereas, almost all S-180 cells were killed inthe same time. The lymphocytes were appeared inabdominal cavity of the mice after treatment ofadriamycin for 24 h. It was very interested to find outthat there was no lymphocyte left in the abdominal cavityof the mice with S-180R cells treated at high dose ofadriamycin.

INDUCTION OF APOPTOSIS IN S-180 AND S-180R TUMOR CELLS BY ADRIAMYCIN IN VIVO

Apoptosis of tumor cells have become a new standard for chemotherapy. It is useful to demonstrate induction of apoptosis in tumor cells by anti-cancer drugs in vivo. We reported the results of apoptosis induction in murine tumor cell line S-180 and it's resistant cell line S-180R by adriamycin in different dose and different time. We found that apoptosis in S-180 cells could be induced by low dose of adriamycin, the apoptosis was started at 24 h. after the administration, and reached to 62.5% of the cells to apptosis until 72 h. Comparison with the parental cell line, only 13% of S-180R cells were apoptosed. At high dose, 20% of S-180R cells were apoptosed, whereas, almost all S-180 cells were killed in the same time. The lymphocytes were appeared in abdominal cavity of the mice after treatment of adriamycin for 24 h. It was very interested to find out that there was no lymphocyte left in the abdominal cavity of the mice with S-180R cells treated at high dose of adriamycin.